August 11, 2022

Ironshore Pharmaceuticals recognizes ADHD Awareness Month through partnership with CHADD

Pin It

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Oct 28, 2019– In recognition of Attention-Deficit/Hyperactivity Disorder (ADHD) Awareness Month, Ironshore Pharmaceuticals Inc. (Ironshore) has partnered with Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) to sponsor an educational webinar to help elevate awareness of ADHD and highlight the challenges that families experience during the early morning routine. In addition to the webinar, Ironshore […]

Ironshore Pharmaceuticals and CHADD to raise awareness about the negative impact of ADHD during the early morning routine

Pin It

GEORGE TOWN, Grand Cayman–(BUSINESS WIRE)–Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., and Children and Adults with Attention-Deficit/Hyperactivity Disorder (“CHADD”), a national non-profit organization providing education, advocacy and support for individuals with ADHD, today announced an agreement whereby Ironshore will sponsor advocacy programs designed to educate parents, teachers and […]